We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Weekly
    • FDAnews
  • Device News
    • Trending
    • Commercial Operations
    • FDA Enforcement Actions
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Weekly
    • FDAnews
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • FDAnews Editorial Board
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » Devices

Devices
Devices RSS Feed RSS

Atossa Genetics’ Breast Health Tests Subject of Class I Recall

November 15, 2013
Seattle-based Atossa Genetics has initiated a Class I recall of all lots of its Mammary Aspiration Specimen Cytology Test (MASCT) and the accompanying patient sample kit, along with the ForeCYTE Breast Health Test Kit, manufactured between Jan. 9 and Sept. 13, 2013. Read More

Patient Groups Press Congress to Protect Access to Medical Imaging

November 15, 2013
A group of patient advocacy organizations is urging Congress to pull back on proposed cuts in Medicare coverage for medical imaging, saying further reductions will seriously impede access to life-saving screening and radiation therapy services. Read More

Smith & Nephew Launches Advanced Biocomposite Implant

November 12, 2013
Smith & Nephew announced the U.S. launch of its Healicoil Regenesorb suture anchor at the Arthroscopy Association of North America Fall Course in Las Vegas. Read More

Zimmer, OrthoSensor Ink Marketing Deal

November 12, 2013
OrthoSensor and Zimmer Holdings have signed a collaborative marketing agreement pairing Zimmer’s NexGen brand of knee replacement systems with OrthoSensor’s Verasense technology in the U.S. and abroad. Read More

CardioInsight Gets $15M Infusion for Heart Mapping Technology

November 11, 2013
CardioInsight, an Ohio-based devicemaker specializing in mapping abnormal heart rhythms, has secured $15 million in long-term strategic financing for its noninvasive ECVUE monitoring system. Read More

FDA Reviewers Doing Better Job of Coordinating Requests on CDx

November 8, 2013
Better communication between CDRH and the Center for Drug Evaluation and Research should translate to fewer requests for duplicate data on companion diagnostic submissions. Read More

Infusion Pumps, Alarms Pose Biggest Health Risks, ECRI Report Finds

November 8, 2013
Infusion medication errors and alarm fatigue remain the leading health technology hazards for the coming year, a new report by the ECRI Institute says. Read More

Unilife Hit With Securities Suit Following Whistleblower Claims

November 8, 2013
Unilife shareholder Byron Brandt has filed a federal securities class-action suit against the devicemaker for alleged false statements about financial performance and quality compliance. Read More

Failure to Report Contractor Rework, Procedure Shortfalls Brings Warning

November 8, 2013
Aptalis, a specification developer for the Flutter mucus clearance device, failed to report a contract manufacturer’s rework of devices to correct issues both this year and in 2012, a recent FDA warning letter says. Read More

Draft Guidance Draws Line Between Hearing Aids, PSAPs

November 8, 2013
A Thursday draft guidance from CDRH attempts to clarify the distinction between hearing aids and personal sound amplification products, or PSAPs. Read More

Cybersecurity, Appeals Top CDRH FY14 List of Final Guidance Goals

November 8, 2013
CDRH plans to roll out 12 final guidance documents in fiscal 2014, including guidances on cybersecurity, the device appeals process and the global unique device identification database, or GUDID, the center revealed Thursday. Read More

FDA Grants FzioMed Petition for Dispute Resolution Panel Review

November 8, 2013
San Luis Obispo, Calif.-based FzioMed said the FDA has agreed to hear its appeal on a decision not to approve the company’s Oxiplex Gel spinal product, a clear, absorbable gel applied during lumbar spine surgery. Read More
Previous 1 2 … 1072 1073 1074 1075 1076 1077 1078 1079 1080 Next

Upcoming Events

  • 28Sep

    The Cost of Counterfeiting: Why You Need a Plan to Secure Your Medical Device Supply Chain

  • 28Sep

    Calculating Sample Size to Satisfy FDA Expectations

  • 11Oct

    GMP Quality Management vSummit 2023: Where Quality Meets Risk

  • 16Oct

    MAGI@home Clinical Research Conference 2023

  • 26Oct

    FDA in 2024: What to Expect in an Election Year

  • 02Nov

    How UDI and UDI Data Can — and Must — Be Used for More Than Just Device Identification

Featured Products

  • FDA, FTC and DOJ Enforcement of Medical Device Regulations

    FDA, FTC and DOJ Enforcement of Medical Device Regulations

  • Using Real-World Evidence in Drug and Device Submissions

    Using Real-World Evidence in Drug and Device Submissions

Featured Stories

  • Expert Says FDA Under No Obligation to Educate Companies on Inspection Rights

  • FDA Deems Hamilton Ventilator Recall Class I for Software Issue Causing Device to Stop

  • Survey Shows Nearly All Pharm Techs Face Drug Shortages, Pfizer Plant Shortages Continue Until 2024

  • FDA Shares Premarket Requirements for Device Cybersecurity in Final Guidance

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing